By synthesizing the results of GSEA and GSVA, we have gained insights into the potential involvement of EFEMP2, GABARAPL1, and TSPO in the pathogenesis of AD and OA within the "bone-brain axis," particularly in the contexts of inflammatory responses, cellular metabolism, immune regulation, and neurodegeneration. This evidence concerns the gene GABARAPL1 and Alzheimer disease.